| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 08/30/2001 | WO2000047738A9 Human and mouse trek-1 potassium channel protein and their use |
| 08/30/2001 | WO2000040733A9 Human cyclic nucleotide pdes |
| 08/30/2001 | WO2000040614A9 Characterization of the soc/crac calcium channel protein family |
| 08/30/2001 | WO2000040597A9 Method and composition for angiogenesis inhibition |
| 08/30/2001 | US20010018642 Method and system for providing a probe array chip design database |
| 08/30/2001 | US20010018558 MR fluoroscopy method and apparatus |
| 08/30/2001 | US20010018514 Nucleic acid labeling compounds |
| 08/30/2001 | US20010018512 For biopolymer |
| 08/30/2001 | US20010018511 Anticancer agent |
| 08/30/2001 | US20010018433 Administering a bisphosphonate compound; prostaglandin antagonist |
| 08/30/2001 | US20010018419 Isolated and purified; Rh antigens which can be immobilized and used in hematology, for isolation and purification of anti-Rh antibodies from solutions; useful in treatment of hemolytic disease of newborn |
| 08/30/2001 | US20010018414 Modified vitamin K-dependent polypeptides |
| 08/30/2001 | US20010018412 Primers specific to the target DNA fragment are immobilized on inner surfaces of the holes of a holder in a vessel; free primer common to the target DNA fragment species is mobile in the vessel with a solution and other reagents |
| 08/30/2001 | US20010018220 Exposing biological fluids to membrane bound, labeled immunoglobin G (IgG) complexing agent; resulting conjugate indicates IgG binding by color change |
| 08/30/2001 | US20010018217 Acrylic amide copolymer crosslinked with diolefins; covalently bonded to pH sensitive fluorescent dyes; physiological solution, i.e. blood; ionic strength-independent |
| 08/30/2001 | US20010018216 Dispensing biological reagents; spaced tandemly arranged substrates; conveyor belt; reagent transfer instrument; micropipette |
| 08/30/2001 | US20010018215 Mixing blood various amounts of activating factors, anticoagulants and platelet inhibitors; measuring clotting times |
| 08/30/2001 | US20010018198 Nucleic acids encoding ataxin-2 binding proteins, products related thereto and methods of using same |
| 08/30/2001 | US20010018196 Method for identifying inhibitors of cytokinesis |
| 08/30/2001 | US20010018195 Prevention cell death |
| 08/30/2001 | US20010018194 Labeling; complexing |
| 08/30/2001 | US20010018192 Labeled cells for use as an internal functional control in rare cell detection assays |
| 08/30/2001 | US20010018191 Immunology complex with epitopes; Alzheimer's disease |
| 08/30/2001 | US20010018190 Predicting sensitivity of prostate cancer |
| 08/30/2001 | US20010018188 Synthetic peptides for the detection of trimethylamine (TMA) and their detection method and device |
| 08/30/2001 | US20010018187 Coreactant-including electrochemiluminescent compounds, methods, systems and kits utilizing same |
| 08/30/2001 | US20010018186 Method for molecular diagnosis of tumor angiogenesis and metastasis |
| 08/30/2001 | US20010018183 Multicolor caomparative hybrid analysis |
| 08/30/2001 | US20010018182 Methods of monitoring disease states and therapies using gene expression profiles |
| 08/30/2001 | US20010018076 Anti-cancer agents isolated from buckwheat rhizomes (Fagospyrum cymosum); high powered liquid chromatography; purity; tannins |
| 08/30/2001 | US20010018042 Animal model for detection of vulnerable plaques |
| 08/30/2001 | US20010017938 Transformation of digital images |
| 08/30/2001 | US20010017270 An optical, piezoelectric, electrochemical electrode or a thermistor sensor in which an immobilized carbohydrate derivative is used to generate a detectable signal when a protein, virus or cell is bound to carbohydrate surface |
| 08/30/2001 | US20010017195 Enables lignin content measurement independently of species variations and pulp consistency |
| 08/30/2001 | DE10028548C1 Verfahren zum Nachweis von alpha-Oxoaldehyden in Vollblut, Blutplasma und/oder Serum eines Patienten A method for detecting alpha-oxoaldehydes in whole blood, blood plasma and / or serum of a patient |
| 08/30/2001 | DE10009503A1 Verfahren zur Immobilisierung von Konjugaten in diagnostischen Tests A process for the immobilization of conjugates in diagnostic assays |
| 08/30/2001 | DE10009410A1 Identifying agents that reduce presentation of antigens in liver sinus endothelial cells comprises identifying substances which inhibit major histocompatability complex (MHC)-1 in sinus endothelial cells |
| 08/30/2001 | DE10009131A1 Verfahren und Vorrichtung zur optischen Detektion von Verunreinigungen, insbesondere Fremdfasern, in längsbewegten Garn Method and device for optical detection of impurities, in particular foreign fibers, in the longitudinal moving yarn |
| 08/30/2001 | DE10008906A1 Testsystem auf Basis von Mikrokapillaren Test system based on microcapillaries |
| 08/30/2001 | DE10008623A1 Pneumatisches Probenahmesystem mit automatisch einstellbarer Dosiermenge Pneumatic sampling system with automatically adjustable dosing quantity |
| 08/30/2001 | DE10008547A1 Verfahren zur Beurteilung des Verschleißes von Motoröl Method for assessing the deterioration of engine oil |
| 08/30/2001 | CA2671940A1 Identification of partial agonists of the a2a adenosine receptor |
| 08/30/2001 | CA2437298A1 Method for correlating blood coagulation activity with markers in body fluids, e.g. urine |
| 08/30/2001 | CA2406864A1 Simultaneous stimulation and concentration of cells |
| 08/30/2001 | CA2401868A1 Molecules for diagnostics and therapeutics |
| 08/30/2001 | CA2401647A1 Inter-alpha-trypsin as a marker for sepsis |
| 08/30/2001 | CA2401360A1 Method for measurement by using long-lived excitation fluorescence |
| 08/30/2001 | CA2401233A1 Method for detecting cytosine methylation in dna samples |
| 08/30/2001 | CA2401198A1 Ligase/polymerase method for detecting cytosine methylation in dna samples |
| 08/30/2001 | CA2401195A1 Pai-2 conjugates for the treatment and imaging of cancer |
| 08/30/2001 | CA2401118A1 Microfluidic devices and methods |
| 08/30/2001 | CA2401113A1 Transporters and ion channels |
| 08/30/2001 | CA2401096A1 Methods and compositions for inhibiting angiogenesis |
| 08/30/2001 | CA2401063A1 Solution and crystal structures of mmp-13 active site and uses thereof |
| 08/30/2001 | CA2401014A1 Methods of structure-based drug design using ms/nmr |
| 08/30/2001 | CA2401011A1 Personal computer breath analyzer for health-related behavior modification and method |
| 08/30/2001 | CA2400948A1 Materials and methods involving hybrid vascular endothelial growth factor dnas and proteins |
| 08/30/2001 | CA2400915A1 Estrogen receptor alpha variants and methods of detection thereof |
| 08/30/2001 | CA2400890A1 Method and system for the assembly of a whole genome using a shot-gun data set |
| 08/30/2001 | CA2400876A1 Novel protein and gene encoding the protein |
| 08/30/2001 | CA2400867A1 Method of screening compounds for biological activity |
| 08/30/2001 | CA2400842A1 Novel compounds |
| 08/30/2001 | CA2400838A1 Novel method for down-regulation of amyloid |
| 08/30/2001 | CA2400831A1 Estrogen receptor beta variants and methods of detection thereof |
| 08/30/2001 | CA2400794A1 New transcription factor carp-2 |
| 08/30/2001 | CA2400789A1 Microarray fabrication techniques and apparatus |
| 08/30/2001 | CA2400669A1 Immunoassay method for the diagnosis of gastric intestinal metaplasia associated with gastric carcinoma |
| 08/30/2001 | CA2400661A1 Novel antibody with specificity for colon cancer |
| 08/30/2001 | CA2400651A1 Electrochemical sensor for determining blood clotting, corresponding system for measuring blood clotting and method for determining blood clotting |
| 08/30/2001 | CA2400642A1 Modified fluorescent proteins |
| 08/30/2001 | CA2400606A1 New phosphodiesterase type 7b |
| 08/30/2001 | CA2400159A1 Chips having elevated sample surfaces |
| 08/30/2001 | CA2400088A1 Differential expression screening method |
| 08/30/2001 | CA2399999A1 Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer |
| 08/30/2001 | CA2399404A1 Screening methods for gram-positive enterococcal virulence factors |
| 08/30/2001 | CA2399259A1 Endometriosis-related markers and uses thereof |
| 08/30/2001 | CA2399258A1 Analysis of biological targets using a biochip comprising a fluorescent marker |
| 08/30/2001 | CA2399241A1 Improved methods for generating catalytic proteins |
| 08/30/2001 | CA2399189A1 Microarray fabrication techniques and apparatus |
| 08/30/2001 | CA2398703A1 Parkin protein as ubiquitin ligase |
| 08/30/2001 | CA2398275A1 Human polynucleotides, polypeptides, and antibodies |
| 08/30/2001 | CA2397742A1 Method for transdermal sampling of analytes |
| 08/30/2001 | CA2370803A1 Methods for identifying a protease inhibitor |
| 08/29/2001 | EP1128310A2 Chemical array fabrication |
| 08/29/2001 | EP1128184A2 Method of measuring chlorine content in aqueous solution |
| 08/29/2001 | EP1128180A2 Control system |
| 08/29/2001 | EP1127944A1 Method for screening compound inhibiting signal transduction of inflammatory cytokine |
| 08/29/2001 | EP1127893A2 Compositions and methods for the treatment and diagnosis of breast cancer |
| 08/29/2001 | EP1127576A1 Uses of NM23-polypeptides in skin and intestinal disorders |
| 08/29/2001 | EP1127536A2 Biochip |
| 08/29/2001 | EP1127277A1 Polyglutamine-containing proteins in neuropsychiatric disorders |
| 08/29/2001 | EP1127276A1 Method and use for marking and identifying applied substances |
| 08/29/2001 | EP1127275A1 Method and apparatus for measuring the load bearing capacity of a platform |
| 08/29/2001 | EP1127274A2 Detectors and their use |
| 08/29/2001 | EP1127271A1 Sensor array and method for determining the density and viscosity of a liquid |
| 08/29/2001 | EP1127268A1 Arrayable thermal assays |
| 08/29/2001 | EP1127259A2 Thromboplastin reagents and methods for preparing and using such reagents |
| 08/29/2001 | EP1127189A2 Method and device for measuring the quality of paper and/or cardboard on moving webs |
| 08/29/2001 | EP1127170A1 Human pan-hcv human monoclonal antibodies |
| 08/29/2001 | EP1127167A1 Methods for preventing cross-contamination in solid support-based assays |